Skip to main content
S 3401 117th Congress Senate Health

ABC Safe Drug Act

Introduced: December 15, 2021 Introduced by: Cotton, Tom Republican · Arkansas See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 15, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 15, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Anyone But China Safe Drug Act or the ABC Safe Drug Act

This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing ingredients manufactured in China, and requires drugs to be labeled for country of origin.

The Food and Drug Administration shall maintain (1) a list of foreign-sourced drugs and active ingredients that are critical for consumer health and safety, and (2) another list identifying such drugs that are produced exclusively in China or use ingredients produced in China.

The bill phases in a restriction on federal health care programs purchasing drugs with active ingredients manufactured in China. By January 1, 2026, such programs may not purchase a drug with any active ingredients from China. The Department of Health and Human Services may issue a waiver for an agency or program that is unable to meet this requirement, but no waiver may apply to drugs purchased in or after 2027.

Each drug must have labeling listing the country of origin of each active ingredient, and a drug without this labeling shall be deemed misbranded.

What's happening now December 15, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
  • HR 7121 Related bill Protecting our Pharmaceutical Supply Chain from China Act of 2022
  • S 2495 Related bill Protecting our Pharmaceutical Supply Chain from China Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3401: ABC Safe Drug Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-3401/
MLA
"S. 3401: ABC Safe Drug Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-3401/.
Bluebook (legal)
S. 3401, 117th Cong. (2026), https://openamerica.io/bill/117-S-3401/.
Markdown link
[S. 3401: ABC Safe Drug Act](https://openamerica.io/bill/117-S-3401/)
Report a problem